However, the current research is not deep enough and lacks experiments in vivo. In our subsequent experiments, the molecular mechanism of the ARHGEF39 regulation on ccRCC cells and the in vivo experiments will be further studied. The gene discussed is ARHGEF39; the disease is nonpapillary renal cell carcinoma.